RMS LIFELINE, LLC.
Has been acquired by
WELLFOUNT CORP.
Has completed its $22,000,000 Debt and Equity financing
UPSTREAM REHABILITATION, LLC
Has been formed by management in collaboration with
FRESENIUS MEDICAL CARE
Through the divestiture of certain assets and the completion of a long-term product supply agreement, has formed
DOW CHEMICAL, INC
Through the “spin –off” of certain assets and sciences, and through the contribution of $20 million of capital from leading institutions, has formed
SORBENT THERAPEUTICS, INC.
Has issued $20,000,000
Series B Preferred Stock
ALINE AESTHETICS
a wholly owned subsidiary of 
Has been acquired by
ORTHOCON, INC.
Has completed a comprehensive review of strategic & financial alternatives
SMARTPILL, INC.
Has been acquired by
QUANTUM OPS, LLC
Has entered into an exclusive distribution agreement with
INLIGHT, INC.
Has issued
$39,000,000
Series B Preferred Stock
PULSE SYSTEMS
Healthios has issued a fairness opinion in conjunction with the acquisition of Pulse Systems
ADVANTEDGE HEALTH SOLUTIONS
Has completed multiple strategic initiatives
SXC HEALTH SOLUTIONS, INC.
Has expanded its management team and Board of Directors with the addition of several leaders with significant experience in the global healthcare industry
iMEDICA, INC.
Has completed a strategic partnership with
ING BARING
Has completed an investment in
BAXTER INTERNATIONAL, INC.
Has completed a strategic review of its dialysis business unit, including a market study of the Wearable Kidney Market and the Chronic Kidney Disease Market
WELLDOC, INC.
Has completed a strategic partnership with
STEADYMED, LTD
Has issued $10,000,000
Series B Preferred Stock
CALIBRA MEDICAL, INC.
Has issued $10,000,000
Senior Subordinated Debt
CORIUM INTERNATIONAL, INC.
$52,000,000
Initial Public Offering
IRX Therapeutics
Has completed a round of financing
ENVISIA THERAPEUTICS, INC.
Has completed a $25 ,000,000 Series A Financing in conjunction with the “spin –off” of certain assets and sciences from Liquidia
BAYER PLASMA, GmBH
An operating division of
Has been acquired by
Cerberus, LLC
ALPHA THERAPEUTICS, INC.
An operating division of
Has been acquired by
PINNACLE BIOLOGICS, INC.
Has completed its $6,000,000 Series A financing
SORBENT THERAPEUTICS, INC.
Has completed its spinout from Dow Chemical
NOVALAR PHARMACEUTICALS, INC.
Has been acquired by
$65,000,000
LIQUIDIA TECHNOLOGIES, INC.
Has completed a global collaboration with
INNFOCUS, LLC
Has completed a structured financing with
BOSTON SCIENTIFIC, INC.
Has completed a strategic review of its endoscopy business unit leading to its decision to optimize strategic alternatives through a tax-efficient “spin-off”
CARDIOSOUTIONS, INC.
Has completed its $15,000,000 Series B financing led by
VERAX BIOMEDICAL, INC.
Has entered a Worldwide Commercialization Partnership with
DEERAC FLUIDICS, INC.
Has been acquired by
CLAROS DIAGNOSTICS, INC.
Has been acquired by
BIOMERIX, INC.
Has completed a Strategic Investment by
MIACOM DIAGNOSTICS
Has completed its equity financing from
CRITICAL PERFUSION, INC.
Has entered into a co-development agreement with
CLEARCOUNT MEDICAL SOLUTIONS, INC.
Has licensed various IP to
NOVADAQ TECHNOLOGIES, INC.
Has completed a review of various divestiture and strategic financing alternatives
PATHWAY MEDICAL TECHNOLOGIES, INC.
Has completed multiple strategic sales and marketing initiatives
BIOSPHERE MEDICAL, INC.
Has completed multiple strategic initiatives
TRIREME MEDICAL, INC.
Has completed its $17,000,000 Series D financing
THE UNDERSIGNED ACTED AS EXCLUSIVE ADVISOR TO TRIREME
TRIREME MEDICAL, INC.
Has entered into an exclusive distribution agreement with
CHEETAH MEDICAL LTD.
Has completed its $20,000,000 Series B financing
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO CHEETAH
BRONCUS TECHNOLOGIES, INC.
Has sold certain emphysema assets to
THE UNDERSIGNED ACTED AS EXCULSIVE
ADVISOR TO BRONCUS
CALIBRA MEDICAL, INC
Has been acquired by
WELLDOC, INC.
Has issued $10,000,000 Series A Preferred Stock
WELLDOC, INC.
Has issued $10,000,000 Series B Preferred Stock
INSPIRATION BIOPHARMACEUTICALS, INC.
Completed a strategic partnership with 
$259,000,000
NANOMIX, INC.
Has completed its $12,000,000 Equity financing by strategic and financial investors
EXAGEN DIAGNOSTICS, INC.
Has completed its $25,000,000
Debt financing
FDBU (a Fujifilm subsidiary) acquires 49% of the total membership interests in Kalon
CORIUM INTERNATIONAL, INC.
Has issued $35 million in Interest-Bearing High Yield Securities
SYNCARDIA SYSTEMS, INC.
Has completed its $11,000,000
Series D financing
THE UNDERSIGNED ACTED AS ADVISOR TO SYNCARDIA